Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Setting Priorities for Comparative Effectiveness Research: From Assessing Public Health Benefits to Being Open With the Public

Abstract (from Health Affairs): Medicine’s current evidence base is insufficient for many of the decisions made daily by clinicians, patients, purchasers, and policy makers. The Patient-Centered Outcomes Research Institute (PCORI) represents an effort by the US government to address this shortcoming by funding comparative effectiveness research (CER). Prioritizing that research will be a critical first step. To better understand components of an optimal process, NPC reviewed the literature and conducted interviews regarding the prioritization efforts of leading public and private health organizations in the United States and abroad. From this review, NPC proposes a framework for prioritization, poses and answers key questions, and makes recommendations regarding application of that framework. NPC also recommends that during the priority-setting process, there should be transparent conversations among those who make decisions about the priorities and the public.

 

View the interview with NPC Chief Science Officer Dr. Robert Dubois and read the press release.

 

About the project:

NPC undertook this research to understand the components of an optimal approach to prioritizing CER. It is especially timely because PCORI is working on its priorities for the CER that it will fund; these priorities will set the tone for all of the institute’s future activities.The research also highlights the difficult questions PCORI will face as the public dialogue on its national research priorities and research agenda begins.

Why prioritization is important:

Not all topics can be studied; there are budget and time constraints that limit what activities can be done. Without setting criteria or defining priorities, one risks including all areas and prioritizing none, an outcome that is not helpful to patients or providers who are looking for answers.

Key recommendations that should be used to make research decision-making processes more effective include:

  • Defining priorities to identify what has greater and lesser importance;
  • Ensuring that all stakeholders are engaged in all aspects of the prioritization process, including identifying topics and prioritizing among them;
  • Using a systematic approach when considering all evidence as it relates to prioritizing topics;
  • Maintaining an open and transparent consensus process which can handle inevitable disagreement;
  • Communicating the process and the results of the process;
  • Allowing for the incorporation of new evidence that takes into account continuing advances in medical care or technology; and
  • Evaluating the results of the process by asking both those involved in the process and the general public. 
Blog Post

CER Tweets of the Week (April 7-11, 2014)

Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this week. They tweeted about the National...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
Blog Post

CER Tweets of the Week (March 31- April 4, 2014)

This week, health care stakeholders on Twitter highlighted the many activities and sessions at the Academy of Managed Care Pharmacy’s (AMCP) 26th...
Blog Post

4/8 Webinar on CER Collaborative: Tools You Can Use

The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Press Release

National Pharmaceutical Council Statement on Appointment of PCORI Board Chair

Washington, DC, September 19, 2013—The National Pharmaceutical Council (NPC) today released the following statement regarding the Government...
Press Release

NPC Comments on Appointment of AHRQ Director

Washington, DC, August 19, 2013—National Pharmaceutical Council (NPC) President Dan Leonard today released the following statement about the...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
YouTube Videos

Leveraging Real-World Data and Analytics in the Device Industry

Thomas Abbott, PhD, head, health care informatics at Johnson & Johnson, Medical Devices and Diagnostics, talks about the impact of big data and...
YouTube Videos

IMEDS: Sentinel and OMOP Programs

Jane Reese-Coulbourne, MS, ChE, executive director of the Reagan-Udall Foundation, talks about the Food and Drug Administration's Sentinel Initiative...
YouTube Videos

Big Data: Its Evolving Use and Challenges

William Crown, PhD, chief scientific officer at Optum Labs, discusses how the use and nature of big data in health care has been evolving in recent...
Blog Post

CER Tweets of the Week (April 7-11, 2014)

Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this week. They tweeted about the National...
Blog Post

CER Tweets of the Week (March 31- April 4, 2014)

This week, health care stakeholders on Twitter highlighted the many activities and sessions at the Academy of Managed Care Pharmacy’s (AMCP) 26th...
Blog Post

4/8 Webinar on CER Collaborative: Tools You Can Use

The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes...
Blog Post

CER Collaborative Rolls Out New Resources to Aid Formulary Decision-Making

A newly published series of peer-reviewed articles developed by the CER Collaborative will help formulary decision-makers more effectively evaluate...

Research

  •  
  • 1 of 42
  • >

Commentary & Testimony